Toyos Clinic

Nashville, Tennessee 37215

2 studies enrolling now · 27 studies all time

What they study most

Adenoviral Conjunctivitis, Allergic Conjunctivitis, Autoimmune Diseases, Bacterial Conjunctivitis, Cataract, Dry Eye, Dry Eye Disease, Dry Eye Syndrome, Dry Eye Syndromes, Glaucoma, Open-Angle, Inflammation, Kerato Conjunctivitis Sicca

Studies at this site

• Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease — Recruiting now
• Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes. — Recruiting now
• RMP-A03 Ocular Suspension in Patients With Pterygium — Completed
• A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease. — Completed
• Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye — Stopped early
• REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients — Completed
• DOMPE -MT Neurotrophic Keratitis — Running, not enrolling
• A Study to Assess the Safety and Efficacy of ECF843 vs Vehicle in Subjects With Dry Eye Disease — Completed
• Prospective Evaluation of Efficacy and Safety of an Intense Pulsed Light Device to Treat Dry Eye Disease" — Completed
• Air Optix Daily Wear Contact Lenses — Completed
• Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye — Completed
• A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye — Completed
• Single Center, Prospective, Randomized, Controlled, Non-significant Risk — Withdrawn before enrolling
• Clinical Efficacy of Two Topical Dry Eye Drops for Central Corneal Stain Clearing Over 90 Days — Status unconfirmed
• Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED) — Completed
• Safety of Tinted Soft Scleral Eye Shields When IPL is Applied on Eyelids — Completed
• Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo — Stopped early
• A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3) — Completed
• Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo — Completed
• Clinical Comparison of Length of Cataract Procedures With Zeiss Lumera Versus Older Zeiss Microscope — Completed
• Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease — Completed
• Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease — Completed
• Effectiveness of Intense Pulsed Light for Improving Dry Eye Syndrome — Completed
• Manuka Eye Droops for Treatment of Allergy — Withdrawn before enrolling
• Efficacy and Safety of Meibomian Gland Dysfunction and Dry Eye With an LED Blue Treatment Device — Withdrawn before enrolling
• Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye Disease — Completed
• Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery — Completed